Associated Papers
The Template-Jumping Editing Approach in F9-Associated Hemophilia B Gene Therapy.
Sattarov R et al.
International Journal of Molecular Sciences, 2025
Missense and nonsense mutations and inhibitor development in patients with hemophilia A and B.
Karimi F et al.
Journal of Thrombosis and Thrombolysis, 2025
Identification of Novel F9 Gene Variants in 143 Vietnamese Patients with Hemophilia B.
Bach KQ et al.
Journal of Blood Medicine, 2025
F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B.
Liu G et al.
Blood, 2023
Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China.
Dou X et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia, 2023
Variant spectrum of F8 and F9 in hemophilia patients from southern China and 26 novel variants.
Li F et al.
Frontiers in Genetics, 2023
Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications.
Kihlberg K et al.
Thrombosis Research, 2022
The Molecular Basis of FIX Deficiency in Hemophilia B.
Shen G et al.
International Journal of Molecular Sciences, 2022
Molecular analysis of severe hemophilia B in Indian families: Identification of mutational hotspot and novel variants.
Agrawal N et al.
International Journal of Laboratory Hematology, 2022
Genetic analysis of carrier status in female members of Japanese hemophilia families.
Shinozawa K et al.
Journal of Thrombosis and Haemostasis : Jth, 2021
Defining the molecular pathology and consequent phenotypes in Egyptian HB patients.
El-Kamah GY et al.
Journal, Genetic Engineering & Biotechnology, 2021
High resolution melting for F9 gene mutation analysis in patients with haemophilia B.
Salviato R et al.
Blood Transfusion = Trasfusione Del Sangue, 2019
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations.
Branchini A et al.
Blood, 2017
Molecular Analysis of Factor VIII and Factor IX Genes in Hemophilia Patients: Identification of Novel Mutations and Molecular Dynamics Studies.
Al-Allaf FA et al.
Journal of Clinical Medicine Research, 2017
Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.
Boylan B et al.
Journal of Thrombosis and Haemostasis : Jth, 2016
A genetic analysis of 23 Chinese patients with hemophilia B.
Wang QY et al.
Scientific Reports, 2016
Hemophilia B: molecular pathogenesis and mutation analysis.
Goodeve AC
Journal of Thrombosis and Haemostasis : Jth, 2015
Risk factors associated with inhibitor development in Chinese patients with haemophilia B.
Zhou J et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia, 2015
Factor IX mutations in hemophilia B patients from Liaoning Province, China.
Cao DH et al.
International Journal of Laboratory Hematology, 2014
Mutation analysis of a cohort of US patients with hemophilia B.
Li T et al.
American Journal of Hematology, 2014
Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
Radic CP et al.
Thrombosis and Haemostasis, 2013
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations.
Pinotti M et al.
Human Mutation, 2012
Successful treatment of an injury bleeding on a patient suffering from mild von Willebrand's disease and predisposition to allergic diseases, with recombinant factor VIIA.
Alesci S et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia, 2011
Identification of novel and recurrent mutations in Tunisian haemophilia B patients.
Elmahmoudi H et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia, 2011
Allelic heterogeneity of molecular events in human coagulation factor IX in Asian Indians. Mutation in brief #965. Online.
Mahajan A et al.
Human Mutation, 2007
Genotype Hemophilia Screening Program Identified 2 Novel Variants Including a Novel Variant (c.5816-2A > G) Causing a Pathogenic Variant of the Factor 8 Gene.
Owaidah T et al.
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/hemostasis, 0